Form D · Other Health Care
Blaire Biomedical, Inc.
Angola, IN · CIK 0001844236
Offering snapshot reported Feb 5, 2021 · SEC filing
- Reported sold
- Yet to sell Offering amount: $489K
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 5, 2021 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-388578
Source: Form D, filed Feb 5, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Melanie Watson | Director |
| Joseph Wolfcale | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
907 S Wayne St Bldg A Ste105
Angola, IN, 46703
Angola, IN, 46703